CANNABIS POLAND S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.647 PLN | +3.03% |
|
+13.51% | +94.29% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2021 | 381K 97.28K | Sales 2022 | 200K 51.02K | Capitalization | 10.17M 2.59M |
|---|---|---|---|---|---|
| Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | 106 x |
| Net cash position 2021 | 48.43K 12.36K | Net cash position 2022 | 263K 67.11K | EV / Sales 2022 | 49.5 x |
| P/E ratio 2021 |
-51.2
x | P/E ratio 2022 |
-15
x | Employees | 2 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 70.42% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.03% | ||
| 1 week | +13.51% | ||
| Current month | +12.13% | ||
| 1 month | +13.31% | ||
| 3 months | -7.97% | ||
| 6 months | +50.82% | ||
| Current year | +94.29% |
1 week
0.57
0.65
1 month
0.530.65
Current year
0.301.04
1 year
0.281.04
3 years
0.183.18
5 years
0.184.29
10 years
0.184.29
| Managers | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 22-10-31 | |
| Corporate Officer/Principal | 52 | - | |
| Chairman | 52 | 16-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 0.647 | +3.03% | 238,267 |
| 24-05-14 | 0.628 | +1.62% | 361,876 |
| 24-05-13 | 0.618 | +3.52% | 469,027 |
| 24-05-10 | 0.597 | +4.19% | 424,691 |
| 24-05-09 | 0.573 | +0.53% | 29,547 |
End-of-day quote Warsaw S.E., May 14, 2024
More quotes
Cannabis Poland SA, formerly Telehorse SA, is a Poland-based company engaged in the Pharmaceutical and Medicine Manufacturing activity. The Company focuses on operating in the field of production and sale of pharmaceutical and medical products, with the main focus on vaporization products containing cannabinoids manufactured from cannabis. The Company also expands its activity to include other products than pharmaceuticals, such as cosmetics, oils containing cannabinoids for human and animals and photovoltaic cells. The Company is engaged in research and development of a Cannabidiol (CBD)/ Tetrahydrocannabinol-based (THC-based) pharmaceutical for use in the treatment of seizures associated with drug-resistant epilepsy.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +94.29% | 8.12M | |
| +41.20% | 4.24B | |
| +136.64% | 2.23B | |
| +153.97% | 84.17M |
- Stock Market
- Equities
- CBD Stock